- Home
- / Jordanian Pharmaceutical Manufacturing
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Jordanian Pharmaceutical Manufacturing financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
JD16.9 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| JOD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 28.2M | 10.0M | 14.4M | 15.8M | 17.0M | 14.6M | 16.9M |
| Cost of goods sold | 11.9M | 6.4M | 8.6M | 9.4M | 8.8M | 9.6M | 8.1M |
| Gross profit | 16.3M | 4.3M | 6.3M | 10.3M | 8.2M | 5.0M | 8.8M |
| Gross profit margin, % | 57.9% | 43.4% | 43.7% | 64.9% | 48.1% | 34.0% | 52.0% |
| Operating expense total | 14.3M | 8.7M | 7.6M | 7.8M | 6.1M | 5.7M | 6.4M |
| Depreciation and amortization | 645.0K | 741.0K | 713.0K | 676.0K | 771.0K | 868.0K | 935.0K |
| EBITDA | 2.2M | (3.5M) | (1.1M) | 2.4M | 3.3M | (522.0K) | 3.9M |
| EBITDA margin, % | 7.7% | -35.5% | -7.7% | 15.1% | 19.6% | -3.6% | 23.2% |
| EBIT | (2.2M) | (3.8M) | (8.1M) | 1.1M | 1.8M | (2.0M) | 1.4M |
| EBIT margin, % | -7.7% | -38.5% | -56.0% | 6.8% | 10.8% | -13.6% | 8.2% |
| Interest expense | 1.8M | 1.1M | 1.5M | 929.0K | 1.3M | 648.0K | 393.0K |
| Pre tax profit | (4.1M) | (5.9M) | (9.6M) | 151.0K | (922.0K) | (2.7M) | 980.0K |
| Income tax expense | 51.0K | 6.0K | 2.1M | 57.0K | (1.1M) | 141.0K | 339.0K |
| Net Income | (4.1M) | (5.9M) | (11.7M) | 94.0K | 218.0K | (2.8M) | 641.0K |